Laurus Labs Limited

LAURUSLABS NSE Healthcare Pharmaceuticals
Nifty 200 Nifty 500 Midcap 50 Midcap 100 Midcap 150 LargeMid 250 F&O
₹1,969.00
+1.23%
Delayed · cached 15 min
Fair Value Analysis →

Frequently asked questions

What sector does Laurus Labs Limited belong to?
Laurus Labs Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.
What is the current share price of LAURUSLABS?
As of the latest available quote, LAURUSLABS traded at ₹1,969.00. This price is delayed and cached for about 15 minutes.
What is the P/E ratio of LAURUSLABS?
Laurus Labs Limited has a price-to-earnings (P/E) ratio of about 97.33. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.
What is the market capitalisation of LAURUSLABS?
The market capitalisation of Laurus Labs Limited is approximately ₹99,417 Cr.
Is Laurus Labs Limited profitable?
For its latest reported financial year, Laurus Labs Limited recorded a net profit margin of about 13.06%.
Does LAURUSLABS pay a dividend?
Laurus Labs Limited does not currently show a dividend yield in our data.
What is the return on equity (ROE) of LAURUSLABS?
Laurus Labs Limited has a return on equity (ROE) of about 18.30%. ROE measures how much profit a company generates relative to shareholders' equity.
What is the 52-week high and low of LAURUSLABS?
Over the past 52 weeks, LAURUSLABS has traded between a low of ₹823.10 and a high of ₹1,981.80.

These answers are generated from reported financial data and live market figures, for educational and informational purposes only.

Educational data only. Not a recommendation to buy, sell or hold any security.